Cart
sales@molnova.com
EZH2-IN-2
CAS No. 2238821-31-1
EZH2-IN-2( ——— )
Catalog No. M39456 CAS No. 2238821-31-1
EZH2-IN-2 is a EZH2 inhibitor extracted from patent WO2018133795A1, Compound Example 69, with an IC50 of 64 nM. EZH2-IN-2 can be used for the research of cancer or precancerous condition related to EZH2 activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | In Stock |
|
| 50MG | Get Quote | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameEZH2-IN-2
-
NoteResearch use only, not for human use.
-
Brief DescriptionEZH2-IN-2 is a EZH2 inhibitor extracted from patent WO2018133795A1, Compound Example 69, with an IC50 of 64 nM. EZH2-IN-2 can be used for the research of cancer or precancerous condition related to EZH2 activity.
-
DescriptionEZH2-IN-2 is a EZH2 inhibitor extracted from patent WO2018133795A1, Compound Example 69, with an IC50 of 64 nM.
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
RecptorEZH2: 64 nM (IC50)
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number2238821-31-1
-
Formula Weight610.79
-
Molecular FormulaC36H46N6O3
-
Purity>98% (HPLC)
-
SolubilityDMSO : 10 mg/mL (16.37 mM; ultraphonic (<60°C); )
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. LIU, Qing Song, et al. Ezh2 inhibitor and use thereof. WO2018133795A1.
molnova catalog
related products
-
Amine-PEG3-Biotin
Amine-PEG3-Biotin can be used as a signal amplification label.
-
Enrofloxacin Hydroch...
Enrofloxacin Hydrochloride is a fluorinated quinolone antibacterial.
-
MS177
MS177 is an effective and fast-acting EZH2 degrader. MS177 is a PROTAC that consists of a CRBN ligand, linker, and a potent enzymatic EZH2 inhibitor C24 (C24 IC50): 12?nM). MS177 effectively depletes both canonical EZH2–PRC2 and noncanonical EZH2–cMyc complexes. MS177 induces leukaemia cell growth inhibition, apoptosis and cell cycle progression arrest.
